{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:46:37Z","timestamp":1791225997562,"version":"4.1.0"},"reference-count":66,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,1,20]],"date-time":"2015-01-20T00:00:00Z","timestamp":1421712000000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Headache"],"published-print":{"date-parts":[[2015,1]]},"abstract":"\n The study aims to provide an updated assessment of the evidence for individual pharmacological therapies for acute migraine treatment. Pharmacological therapy is frequently required for acutely treating migraine attacks. The\n A<\/jats:styled-content>\n merican\n A<\/jats:styled-content>\n cademy of\n N<\/jats:styled-content>\n eurology\n G<\/jats:styled-content>\n uidelines published in 2000 summarized the available evidence relating to the efficacy of acute migraine medications. This review, conducted by the members of the\n G<\/jats:styled-content>\n uidelines\n S<\/jats:styled-content>\n ection of the\n A<\/jats:styled-content>\n merican\n H<\/jats:styled-content>\n eadache\n S<\/jats:styled-content>\n ociety, is an updated assessment of evidence for the migraine acute medications. A standardized literature search was performed to identify articles related to acute migraine treatment that were published between 1998 and 2013. The\n A<\/jats:styled-content>\n merican\n A<\/jats:styled-content>\n cademy of\n N<\/jats:styled-content>\n eurology\n G<\/jats:styled-content>\n uidelines\n D<\/jats:styled-content>\n evelopment procedures were followed. Two authors reviewed each abstract resulting from the search and determined whether the full manuscript qualified for review. Two reviewers studied each qualifying full manuscript for its level of evidence. Level\n A<\/jats:styled-content>\n evidence requires at least 2\n C<\/jats:styled-content>\n lass\n I<\/jats:styled-content>\n studies, and\n L<\/jats:styled-content>\n evel\n B<\/jats:styled-content>\n evidence requires 1\n C<\/jats:styled-content>\n lass\n I<\/jats:styled-content>\n or 2\n C<\/jats:styled-content>\n lass\n II<\/jats:styled-content>\n studies. The specific medications \u2013 triptans (almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan [oral, nasal spray, injectable, transcutaneous patch], zolmitriptan [oral and nasal spray]) and dihydroergotamine (nasal spray, inhaler) are effective (\n L<\/jats:styled-content>\n evel\n A<\/jats:styled-content>\n ). Ergotamine and other forms of dihydroergotamine are probably effective (\n L<\/jats:styled-content>\n evel\n B<\/jats:styled-content>\n ). Effective nonspecific medications include acetaminophen, nonsteroidal anti\u2010inflammatory drugs (aspirin, diclofenac, ibuprofen, and naproxen), opioids (butorphanol nasal spray), sumatriptan\/naproxen, and the combination of acetaminophen\/aspirin\/caffeine (\n L<\/jats:styled-content>\n evel\n A<\/jats:styled-content>\n ). Ketoprofen, intravenous and intramuscular ketorolac, flurbiprofen, intravenous magnesium (in migraine with aura), and the combination of isometheptene compounds, codeine\/acetaminophen and tramadol\/acetaminophen are probably effective (\n L<\/jats:styled-content>\n evel\n B<\/jats:styled-content>\n ). The antiemetics prochlorperazine, droperidol, chlorpromazine, and metoclopramide are probably effective (\n L<\/jats:styled-content>\n evel\n B<\/jats:styled-content>\n ). There is inadequate evidence for butalbital and butalbital combinations, phenazone, intravenous tramadol, methadone, butorphanol or meperidine injections, intranasal lidocaine, and corticosteroids, including dexamethasone (\n L<\/jats:styled-content>\n evel\n C<\/jats:styled-content>\n ). Octreotide is probably not effective (\n L<\/jats:styled-content>\n evel\n B<\/jats:styled-content>\n ). There is inadequate evidence to refute the efficacy of ketorolac nasal spray, intravenous acetaminophen, chlorpromazine injection, and intravenous granisetron (\n L<\/jats:styled-content>\n evel\n C<\/jats:styled-content>\n ). There are many acute migraine treatments for which evidence supports efficacy. Clinicians must consider medication efficacy, potential side effects, and potential medication\u2010related adverse events when prescribing acute medications for migraine. Although opioids, such as butorphanol, codeine\/acetaminophen, and tramadol\/acetaminophen, are probably effective, they are not recommended for regular use.\n <\/jats:p>","DOI":"10.1111\/head.12499","type":"journal-article","created":{"date-parts":[[2015,1,20]],"date-time":"2015-01-20T13:04:23Z","timestamp":1421759063000},"page":"3-20","source":"Crossref","is-referenced-by-count":506,"title":["The Acute Treatment of Migraine in Adults: The\n A<\/scp>\n merican\n H<\/scp>\n eadache\n S<\/scp>\n ociety Evidence Assessment of Migraine Pharmacotherapies"],"prefix":"10.1111","volume":"55","author":[{"given":"Michael J.","family":"Marmura","sequence":"first","affiliation":[{"name":"Department of Neurology Jefferson Headache Center Thomas Jefferson University Philadelphia PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Silberstein","sequence":"additional","affiliation":[{"name":"Department of Neurology Mayo Clinic Arizona Scottsdale AZ USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd J.","family":"Schwedt","sequence":"additional","affiliation":[{"name":"Department of Neurology Jefferson Headache Center Thomas Jefferson University Philadelphia PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,1,20]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03480010072027"},{"key":"e_1_2_8_3_1","first-page":"627","article-title":"The International Classification of Headache Disorders, 3rd edition (beta version)","volume":"33","author":"Headache Classification of the International Headache Society","year":"2013","journal-title":"Cephalalgia"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182535d0c"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.6.754"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102411417901"},{"key":"e_1_2_8_7_1","volume-title":"Clinical Practice Guideline Process Manual","author":"American Academy of Neurology","year":"2011"},{"key":"e_1_2_8_8_1","volume-title":"Clinical Practice Guidelines We Can Trust","author":"Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines","year":"2011"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.10.1811"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2000.00091.x"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01546.x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2006.00686.x"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2005.05151.x"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2002.00372.x"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2003.03043.x"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2002.00300.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2005.00981.x"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2003.00554.x"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2004.00914.x"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.42.s2.5.x"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2002.02012.x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079904X2745"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2005.01076.x"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1999.019005525.x"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2006.00466.x"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2007.01313.x"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2011.02027.x"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410390399"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(04)90020-3"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.04.003"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.03.013"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2012.02198.x"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102409359314"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.13.1443"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2009.01458.x"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X28926"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200418150-00007"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200519020-00003"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2005.05004.x"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2009.01453.x"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2011.01869.x"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1983.0302129.x"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1997.3701012.x"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.22.3486"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.07.002"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-4679(02)00502-4"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000042477.63516.B2"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2004.00764.x"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2002.02076.x"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2005.05065.x"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1993.1302117.x"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1991.1102059.x"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1999.019004232.x"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2007.01236.x"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2005.01064.x"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410367523"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2001.041007665.x"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102412451359"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2005.00264.x"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.07.017"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2004.00807.x"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2002.00364.x"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2004.00840.x"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2004.04010.x"},{"key":"e_1_2_8_65_1","first-page":"59","article-title":"Safety and efficacy of intravenous sodium valproate in the treatment of acute migraine","volume":"28","author":"Waberzinek G","year":"2007","journal-title":"Neuro Endocrinol Lett"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000147332.41993.90"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2006.00313.x"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhead.12499","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/head.12499","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:17:53Z","timestamp":1762078673000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/head.12499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.1111\/head.12499"],"URL":"https:\/\/doi.org\/10.1111\/head.12499","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}